Skip to main navigation Skip to search Skip to main content
No photo of Raanan Berger

View Scopus Profile

Raanan Berger

Professor

1995 …2026

Research activity per year

Fingerprint

Dive into the research topics where Raanan Berger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer Treatment

    Bar, V., Zundelevich, A., Gavert, N., Aharon, S., Ibrahim, B., Kosenko, A., Neev, G., Viner, R., Straussman, R., Berger, R. & Salpeter, S. J., Jun 2026, In: Journal of Personalized Medicine. 16, 6, 298.

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • Worldwide Innovative Network Consortium: Building a Common Global Cancer Database

    Farahnak, F., El-Deiry, W. S., Lussier, Y. A., Kurzrock, R., Magidi, S., Bresson, C., Enger, S. A., Liu, J., Bar, J., Warner, J. L., Meissner, T., Rubin, E., Rueter, J., Gaddipati, H., Kulkarni, M., Chen, Z., Limaye, S., Elsey, R., Rubenstein, B. M. & Joshua, A. M. & 30 others, Al-Shamsi, H. O., Musallam, K. M., Wunder, F., Raynaud, J., Berchem, G., Gantenbein, M., Al Omari, A., Dermime, S., Abdel-Razeq, H., Saintigny, P., Cervantes, A., Reddel, R. R., Aref, A. T., Martin-Liberal, J., Lázaro, C., Romera, D. C., Sekacheva, M., Berger, R., Pramesh, C. S., Berindan-Neagoe, I., Girda, E., Piris-Gimenez, A., Farhangfar, C. J., Salem, M. E., Dienstmann, R., Salazar, R., Frankel, N. Z., Batist, Z., Quintana, Y. & Batist, G., Aug 2026, In: JCO Global Oncology. 12, 8, e2500720.

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

    Choueiri, T. K., Penkov, K., Uemura, H., Campbell, M. T., Pal, S., Kollmannsberger, C., Lee, J. L., Venugopal, B., van den Eertwegh, A. J. M., Negrier, S., Gurney, H., Albiges, L., Berger, R., Haanen, J. B. A. G., Oyervides Juárez, V., Rini, B. I., Larkin, J., Nolè, F., Schmidinger, M. & Atkins, M. B. & 7 others, Tomita, Y., Ellers-Lenz, B., Hoffman, J., Sandner, R., Wang, J., di Pietro, A. & Motzer, R. J., Apr 2025, In: Annals of Oncology. 36, 4, p. 387-392 6 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    53 Scopus citations

  • Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients

    El-Deiry, W. S., Bresson, C., Wunder, F., Carneiro, B. A., Dizon, D. S., Warner, J. L., Graff, S. L., Azzoli, C. G., Wong, E. T., Cheng, L., Mani, S. A., Safran, H. P., Williams, C., Meissner, T., Solomon, B., Rubin, E., Porgador, A., Berchem, G., Saintigny, P. & Onn, A. & 67 others, Bar, J., Berger, R., Gantenbein, M., Chen, Z., de Pádua Souza, C., Reis, R. M. V., Sekacheva, M., Cervantes, A., Dahut, W. L., Annunziata, C. M., Gober, K., Musallam, K. M., Al-Shamsi, H. O., Abu-Gheida, I., Salazar, R., Limaye, S., Aref, A. T., Reddel, R. R., Al Homsi, M. U., Rouf, A., Dermime, S., Al Suwaidi, J., Vlad, C., Buiga, R., Al Omari, A., Abdel-Razeq, H., Oñate-Ocaña, L. F., Nielsen, F. C., Graham, L., Rueter, J., Joshua, A. M., Girda, E., Libutti, S., Riedlinger, G., Salem, M. E., Farhangfar, C. J., Mesa, R. A., Faltas, B. M., Elemento, O., Pramesh, C. S., Sengar, M., Aoyama, S., Ikeda, S., Berindan-Neagoe, I., Gaddipati, H., Kulkarni, M., Auzias, E., Gerogianni, M., Wolikow, N., Istolainen, S., Schlafrig, P., Frankel, N. Z., Ferraro, A. R., Palma, J., Gimenez, A. P., Hernando-Calvo, A., Felip, E., Tsimberidou, A. M., Herbst, R. S., Tabernero, J., Schilsky, R. L., Liu, J., Lussier, Y., Raynaud, J., Batist, G., Magidi, S. & Kurzrock, R., 2025, In: Oncotarget. 16, 1, p. 140-162 23 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    7 Scopus citations

  • Avelumab + axitinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): Final overall survival (OS) analysis from the JAVELIN Renal 101 phase 3 trial.

    Motzer, R. J., Penkov, K., Uemura, H., Campbell, M. T., Kollmannsberger, C. K., Lee, J. L., Venugopal, B., Van Den Eertwegh, A., Negrier, S., Gurney, H., Albiges, L., Berger, R., Haanen, J., Rini, B. I., Larkin, J., Schmidinger, M., Sandner, R., Wang, J., Di Pietro, A. & CHOUEIRI, T. K., Jun 2024, In: Journal of Clinical Oncology. 42, 16, p. 4508 1 p.

    Research output: Contribution to journal › Article › peer-review

    25 Scopus citations
View all 113 Research outputs